These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 32320006)

  • 1. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans.
    Remie CME; Roumans KHM; Moonen MPB; Connell NJ; Havekes B; Mevenkamp J; Lindeboom L; de Wit VHW; van de Weijer T; Aarts SABM; Lutgens E; Schomakers BV; Elfrink HL; Zapata-Pérez R; Houtkooper RH; Auwerx J; Hoeks J; Schrauwen-Hinderling VB; Phielix E; Schrauwen P
    Am J Clin Nutr; 2020 Aug; 112(2):413-426. PubMed ID: 32320006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin-resistant men.
    Dollerup OL; Chubanava S; Agerholm M; Søndergård SD; Altıntaş A; Møller AB; Høyer KF; Ringgaard S; Stødkilde-Jørgensen H; Lavery GG; Barrès R; Larsen S; Prats C; Jessen N; Treebak JT
    J Physiol; 2020 Feb; 598(4):731-754. PubMed ID: 31710095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects.
    Dollerup OL; Christensen B; Svart M; Schmidt MS; Sulek K; Ringgaard S; Stødkilde-Jørgensen H; Møller N; Brenner C; Treebak JT; Jessen N
    Am J Clin Nutr; 2018 Aug; 108(2):343-353. PubMed ID: 29992272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinamide riboside supplementation does not alter whole-body or skeletal muscle metabolic responses to a single bout of endurance exercise.
    Stocks B; Ashcroft SP; Joanisse S; Dansereau LC; Koay YC; Elhassan YS; Lavery GG; Quek LE; O'Sullivan JF; Philp AM; Wallis GA; Philp A
    J Physiol; 2021 Mar; 599(5):1513-1531. PubMed ID: 33492681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnitine supplementation improves metabolic flexibility and skeletal muscle acetylcarnitine formation in volunteers with impaired glucose tolerance: A randomised controlled trial.
    Bruls YM; de Ligt M; Lindeboom L; Phielix E; Havekes B; Schaart G; Kornips E; Wildberger JE; Hesselink MK; Muoio D; Schrauwen P; Schrauwen-Hinderling VB
    EBioMedicine; 2019 Nov; 49():318-330. PubMed ID: 31676389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide riboside has minimal impact on energy metabolism in mouse models of mild obesity.
    Cartwright DM; Oakey LA; Fletcher RS; Doig CL; Heising S; Larner DP; Nasteska D; Berry CE; Heaselgrave SR; Ludwig C; Hodson DJ; Lavery GG; Garten A
    J Endocrinol; 2021 Sep; 251(1):111-123. PubMed ID: 34370682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD
    Elhassan YS; Kluckova K; Fletcher RS; Schmidt MS; Garten A; Doig CL; Cartwright DM; Oakey L; Burley CV; Jenkinson N; Wilson M; Lucas SJE; Akerman I; Seabright A; Lai YC; Tennant DA; Nightingale P; Wallis GA; Manolopoulos KN; Brenner C; Philp A; Lavery GG
    Cell Rep; 2019 Aug; 28(7):1717-1728.e6. PubMed ID: 31412242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis.
    Pham TX; Bae M; Kim MB; Lee Y; Hu S; Kang H; Park YK; Lee JY
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2451-2463. PubMed ID: 31195117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults.
    Conze D; Brenner C; Kruger CL
    Sci Rep; 2019 Jul; 9(1):9772. PubMed ID: 31278280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide riboside supplementation exerts an anti-obesity effect and prevents inflammation and fibrosis in white adipose tissue of female diet-induced obesity mice.
    Kim MB; Pham TX; vanLuling M; Kostour V; Kang H; Corvino O; Jang H; Odell W; Bae M; Park YK; Lee JY
    J Nutr Biochem; 2022 Sep; 107():109058. PubMed ID: 35643283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise training and NR supplementation to improve muscle mass and fitness in adolescent and young adult hematopoietic cell transplant survivors: a randomized controlled trial {1}.
    Song M; Armenian SH; Bhandari R; Lee K; Ness K; Putt M; Lindenfeld L; Manoukian S; Wade K; Dedio A; Guzman T; Hampton I; Lin K; Baur J; McCormack S; Mostoufi-Moab S
    BMC Cancer; 2022 Jul; 22(1):795. PubMed ID: 35854224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.
    Fletcher RS; Ratajczak J; Doig CL; Oakey LA; Callingham R; Da Silva Xavier G; Garten A; Elhassan YS; Redpath P; Migaud ME; Philp A; Brenner C; Canto C; Lavery GG
    Mol Metab; 2017 Aug; 6(8):819-832. PubMed ID: 28752046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAD
    Crisol BM; Veiga CB; Braga RR; Lenhare L; Baptista IL; Gaspar RC; Muñoz VR; Cordeiro AV; da Silva ASR; Cintra DE; Moura LP; Pauli JR; Ropelle ER
    Eur J Nutr; 2020 Sep; 59(6):2427-2437. PubMed ID: 31494696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease.
    Brakedal B; Dölle C; Riemer F; Ma Y; Nido GS; Skeie GO; Craven AR; Schwarzlmüller T; Brekke N; Diab J; Sverkeli L; Skjeie V; Varhaug K; Tysnes OB; Peng S; Haugarvoll K; Ziegler M; Grüner R; Eidelberg D; Tzoulis C
    Cell Metab; 2022 Mar; 34(3):396-407.e6. PubMed ID: 35235774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term nicotinamide riboside treatment improves muscle quality and function in mice and increases cellular energetics and differentiating capacity of myogenic progenitors.
    Seldeen KL; Shahini A; Thiyagarajan R; Redae Y; Leiker M; Rajabian N; Dynka A; Andreadis ST; Troen BR
    Nutrition; 2021; 87-88():111189. PubMed ID: 33744645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.
    Yoshino M; Yoshino J; Kayser BD; Patti GJ; Franczyk MP; Mills KF; Sindelar M; Pietka T; Patterson BW; Imai SI; Klein S
    Science; 2021 Jun; 372(6547):1224-1229. PubMed ID: 33888596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined epigallocatechin-3-gallate and resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: a randomized controlled trial.
    Most J; Timmers S; Warnke I; Jocken JW; van Boekschoten M; de Groot P; Bendik I; Schrauwen P; Goossens GH; Blaak EE
    Am J Clin Nutr; 2016 Jul; 104(1):215-27. PubMed ID: 27194304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity.
    Cantó C; Houtkooper RH; Pirinen E; Youn DY; Oosterveer MH; Cen Y; Fernandez-Marcos PJ; Yamamoto H; Andreux PA; Cettour-Rose P; Gademann K; Rinsch C; Schoonjans K; Sauve AA; Auwerx J
    Cell Metab; 2012 Jun; 15(6):838-47. PubMed ID: 22682224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide Riboside Enhances In Vitro Beta-adrenergic Brown Adipose Tissue Activity in Humans.
    Nascimento EBM; Moonen MPB; Remie CME; Gariani K; Jörgensen JA; Schaart G; Hoeks J; Auwerx J; van Marken Lichtenbelt WD; Schrauwen P
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1437-1447. PubMed ID: 33524145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fat mobilization without weight loss is a potentially rapid response to nicotinamide riboside in obese people: it's time to test with exercise.
    Fluharty NT; Brenner C
    Am J Clin Nutr; 2020 Aug; 112(2):243-244. PubMed ID: 32412605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.